	普通股股本		日
Acadia Pharmaceuticals	USD 172.31M	174K	2026-09
Adma Biologics	USD 225.36M	6.93M	2026-06
ALKERMES	USD 168.03M	489K	2026-09
Alterity Therapeutics Limited	AUD 10.88B	10.66B	2025-12
AstraZeneca	USD 1.55B	28K	2026-09
BioCryst Pharmaceuticals	USD 255.26M	42.2M	2026-06
Bristol-Myers Squibb	USD 2.04B	7M	2026-06
Cipla	INR 807.87M	88K	2026-09
Clal Biotechnology	ILS 1.61M	0	2022-12
Compugen	USD 94.72M	170K	2026-06
CSL	USD 482.13M	93.87M	2025-12
Eli Lilly	USD 943.5M	3.33M	2026-03
GlaxoSmithKline	GBP 2.02B	2.05B	2026-09
Grifols	EUR 680.58M	846.11K	2025-12
Halozyme Therapeutics	USD 113.94M	106K	2026-09
Ionis Pharmaceuticals	USD 165.64M	265K	2026-06
J&J	USD 2.41B	1.64M	2026-06
Merck	USD 2.47B	1.05M	2026-06
Minerva Neurosciences	USD 1000	0	2024-09
Neurocrine Biosciences	USD 101.3M	750K	2026-09
Novartis	USD 1.89B	12.09M	2026-09
Novavax	USD 162.58M	106K	2025-12
Pfizer	USD 5.7B	0	2026-06
Roche Holding	CHF 796.77M	1.15M	2026-06
Sanofi	EUR 1.2B	0	2026-09
Takeda	JPY 1.58B	460K	2026-06
Vanda Pharmaceuticals	USD 58K	0	2024-12